TY - JOUR AU - Li, Xin-Ru AU - Zhu, Yi AU - Zhang, Guo-Nan AU - Huang, Jian-Ming AU - Pei, Li-Xia PY - 2021 DA - 2021/03/09 TI - The impact of Pegylated liposomal doxorubicin in recurrent ovarian cancer: an updated meta-analysis of randomized clinical trials JO - Journal of Ovarian Research SP - 42 VL - 14 IS - 1 AB - Previous meta-analysis studies suggested that pegylated liposomal doxorubicin (PLD) may improve the survival rate of patients with recurrent ovarian cancer. The aim of the present meta-analysis, then, was to further update the role of PLD in the treatment of recurrent ovarian cancer. SN - 1757-2215 UR - https://doi.org/10.1186/s13048-021-00790-4 DO - 10.1186/s13048-021-00790-4 ID - Li2021 ER -